VP, Marketing and Business Development
Maker of the ACE Alera Clinical Chemistry System
Source for Sensitive Autoimmune Diagnostics
Michael E. Jackson, PhD, Division Manager
Clinical Systems Division
Maker of the D-10, VARIANT II and VARIANT II TURBO
Hemoglobin Testing Systems
Mary Catherine Coyle, MS, MT(ASCP)
Director, Product Marketing Hospital Point of Care
Roche Diagnostics Corp.
Maker of ACCU-CHEK blood-glucose monitoring systems
Director of Marketing, Point of Care
Siemens Healthcare Diagnostics
Maker of the DCA Vantage diabetes analyzer
Philip G. Shugart
Carolina Liquid Chemistries Corp.
Marketer of GlycoMark blood test; maker of BioLis 24i
Robert W. Ban, PhD
Source for Laboratory Quality Control Materials
Maker of StatStrip Hospital Glucose Monitors and
StatStrip Multi-Well Test Strips
Discovery holds promise for treatment of diabetes
Two University of Georgia animal science researchers have 13 pigs that may hold the key to new therapies to treat human diseases, including diabetes. The discovery marks the first time pluripotent stem cells have been created from adult livestock, presenting the possibility of a method to make pigs that can be a source of cells and organs for regenerative medicine in a meaningful way, according to the researchers. The technique called induced pluripotent stem cells had previously been shown to make live offspring in mice. The discovery is a new tool for researchers who need to determine which sources of cells, adult or earlier stages such as embryonic or induced pluripotent stem cells, will work best for each disease. The new process will be valuable for a research project under way in partnership with Emory University to find better therapies for diabetes. Details of the discovery were be published in Stem Cells and Development in June. View a graphic of the process at http://tiny.cc/d7pcg or a fact sheet at http://tiny.cc/fkogl.